Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study

1. Ortega, V.
2. Antón, A.
3. Garau, I.
4. Afonso, N.
5. Calvo, L.
6. Fernández, Y.
7. Martínez-García, M.
8. Blanco, E.
9. Zamora, P.
10. García, M.
11. Illarramendi, J.J.
12. Rodríguez Sánchez, C.A.
13. Sampayo, M.
14. Aguirre, E.
15. Pérez-García, J.M.
16. Cortés, J.
17. Llombart-Cussac, A.